Search
for
Sort by
Research 61–90 of 1000+
- Selective non-steroidal inhibitors of 5α-reductase type 1
- Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients
- Sulfatase inhibitors: a patent review
- Clinical application of 5α-reductase inhibitors
- JAK-inhibitors in dermatology: current evidence and future applications
- SYK inhibitor entospletinib prevents ocular and skin GVHD in mice
- Aromatase-independent testosterone conversion into estrogenic steroids is inhibited by a 5α-reductase inhibitor
- Dermatological side effects of epidermal growth factor receptor inhibitors: ′Pride′ complex
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature
- Persistent hair growth during treatment with the EGFR inhibitor erlotinib
- Semiology of skin toxicity associated with epidermal growth factor receptor (EGFR) inhibitors
- Cutaneous side-effects of EGFR inhibitors and their management.
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- Intravaginal Testosterone Improves Sexual Satisfaction and Vaginal Symptoms Associated With Aromatase Inhibitors
- Estrogenic Potential of 2-Alkyl-4-(thio)chromenone 6-<i>O</i>-Sulfamates: Potent Inhibitors of Human Steroid Sulfatase
- Erosive Pustular Dermatosis of the Scalp-Like Eruption due to Gefitinib: Case Report and Review of the Literature of Alopecia Associated with EGFR Inhibitors
- Histone deacetylase inhibitors promote neurosteroid‐mediated cell differentiation and enhance serotonin‐stimulated brain‐derived neurotrophic factor gene expression in rat C6 glioma cells
- Aromatase inhibitor therapy and hair loss among breast cancer survivors
- Intermittent treatment with farnesyltransferase inhibitor and sulforaphane improves cellular homeostasis in Hutchinson-Gilford progeria fibroblasts
- The management of EGFR inhibitor adverse events: a case series and treatment paradigm
- Cutaneous adverse effects of BRAF inhibitors in metastatic malignant melanoma, a prospective study in 20 patients.
- EGFR Inhibitors and Cutaneous Complications: A Practical Approach to Management
- Benzo[<i>c</i>]quinolizin-3-ones: A Novel Class of Potent and Selective Nonsteroidal Inhibitors of Human Steroid 5α-Reductase 1
- Novel Lead Generation through Hypothetical Pharmacophore Three-Dimensional Database Searching: Discovery of Isoflavonoids as Nonsteroidal Inhibitors of Rat 5α-Reductase
- Activation of TRPV3 Inhibits Lipogenesis and Stimulates Production of Inflammatory Mediators in Human Sebocytes—A Putative Contributor to Dry Skin Dermatoses
- Progesterone Inhibits the Growth of Human Neuroblastoma: In Vitro and In Vivo Evidence
- Expression of<i>Sfrp2</i>Is Increased in Catagen of Hair Follicles and Inhibits Keratinocyte Proliferation
- Steroid sulfatase inhibitors
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream